Brian Song

Brian Song

Auto-generated profile, based on publicly available information

Brian Song

Research Service, VA Ann Arbor Healthcare System; Ann Arbor, Michigan, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2025 in Molecular Cancer Therapeutics
Verified
Journal Article
Closed access
BSBrian Song
Brian Song
HQHeineken Queen
Heineken Queen
SFSarah F. Ferris
Sarah F. Ferris
RMReliza McGinnis
Reliza McGinnis
CKChaitanya Karanam
Chaitanya Karanam
AGAnutosh Ganguly
Anutosh Ganguly
Histotripsy-focused ultrasound treatment gives rise to systemic antitumor immune responses. We investigated whether histotripsy effects on immunosuppressive tumor hypoxia were a potential mechanism for these immunostimulatory effects. Immunocompetent or CD8-deficient C57BL/6 mice with flank B16F10 or YUMM1.7 melanoma tumors underwent sham or subtotal histotripsy. Tumor growth, immune cell infiltration, and intratumoral hypoxia responses were examined using flow cytometry and fluorescence microscopy. Chemokine receptor CXCR3 and hypoxia-inducible factor-1α (HIF1α) were intercepted with antibodies and inhibitors to assess their roles in immune responses after histotripsy. Histotripsy-treated tumors exhibited rapid loss of intratumoral hypoxia and suppression of HIF1α and downstream prosurvival proteins. Histotripsy was followed by intratumoral upregulation of the CXCR3 ligand CXCL10 and CXCR3+/CD8+ T-cell infiltration. Tumor growth inhibition by histotripsy was significantly diminished in CD8-deficient mice and mice receiving anti-CXCR3 mAb. Post-histotripsy inhibition of hypoxia and tumor growth eventually receded in parallel with cessation of CD8+ T-cell influx, and pharmacologic HIF1α suppression with the MEK inhibitor trametinib substantially augmented the therapeutic effects of histotripsy. Transient abrogation of intratumoral hypoxia and HIF1α-associated hypoxia responses is mechanistically linked with intratumoral infiltration of activated CXCR3+/CD8+ T cells via CXCL10–CXCR3 engagement. These findings suggest that the immune effects of histotripsy may be regulated by hypoxia abrogation and that pharmacologic hypoxia abrogation could potentiate the immunotherapeutic effects of histotripsy.

2 July 2025
Verified
Other
Open access
PDF file
BSBrian Song
Brian Song
HQHeineken Queen
Heineken Queen
SFSarah F. Ferris
Sarah F. Ferris
RMReliza McGinnis
Reliza McGinnis
CKChaitanya Karanam
Chaitanya Karanam
AGAnutosh Ganguly
Anutosh Ganguly
Supplementary Figure S3: Validation of VG1 Antibody by immunofluorescence.

2 July 2025
Verified
Other
Open access
PDF file
BSBrian Song
Brian Song
HQHeineken Queen
Heineken Queen
SFSarah F. Ferris
Sarah F. Ferris
RMReliza McGinnis
Reliza McGinnis
CKChaitanya Karanam
Chaitanya Karanam
AGAnutosh Ganguly
Anutosh Ganguly
Supplementary Figure S6: Effect of Trametinib on HIF-1α expression after 4 hours of in vitro exposure to cultured B16F10.

2 July 2025
Verified
Other
Open access
PDF file
BSBrian Song
Brian Song
HQHeineken Queen
Heineken Queen
SFSarah F. Ferris
Sarah F. Ferris
RMReliza McGinnis
Reliza McGinnis
CKChaitanya Karanam
Chaitanya Karanam
AGAnutosh Ganguly
Anutosh Ganguly
Supplementary Figure S8: Flow cytometric analysis of the phenotype of tumor-infiltrating CD8+ T cells between tumors treated with or without histotripsy or Trametinib.

2 July 2025
Verified
Other
Open access
BSBrian Song
Brian Song
HQHeineken Queen
Heineken Queen
SFSarah F. Ferris
Sarah F. Ferris
RMReliza McGinnis
Reliza McGinnis
CKChaitanya Karanam
Chaitanya Karanam
AGAnutosh Ganguly
Anutosh Ganguly
Histotripsy-focused ultrasound treatment gives rise to systemic antitumor immune responses. We investigated whether histotripsy effects on immunosuppressive tumor hypoxia were a potential mechanism for these immunostimulatory effects. Immunocompetent or CD8-deficient C57BL/6 mice with flank B16F10 or YUMM1.7 melanoma tumors underwent sham or subtotal histotripsy. Tumor growth, immune cell infiltration, and intratumoral hypoxia responses were examined using flow cytometry and fluorescence microscopy. Chemokine receptor CXCR3 and hypoxia-inducible factor-1α (HIF1α) were intercepted with antibodies and inhibitors to assess their roles in immune responses after histotripsy. Histotripsy-treated tumors exhibited rapid loss of intratumoral hypoxia and suppression of HIF1α and downstream prosurvival proteins. Histotripsy was followed by intratumoral upregulation of the CXCR3 ligand CXCL10 and CXCR3+/CD8+ T-cell infiltration. Tumor growth inhibition by histotripsy was significantly diminished in CD8-deficient mice and mice receiving anti-CXCR3 mAb. Post-histotripsy inhibition of hypoxia and tumor growth eventually receded in parallel with cessation of CD8+ T-cell influx, and pharmacologic HIF1α suppression with the MEK inhibitor trametinib substantially augmented the therapeutic effects of histotripsy. Transient abrogation of intratumoral hypoxia and HIF1α-associated hypoxia responses is mechanistically linked with intratumoral infiltration of activated CXCR3+/CD8+ T cells via CXCL10–CXCR3 engagement. These findings suggest that the immune effects of histotripsy may be regulated by hypoxia abrogation and that pharmacologic hypoxia abrogation could potentiate the immunotherapeutic effects of histotripsy.

24 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
HQHeineken Queen
Heineken Queen
BSBrian Song
Brian Song
HKHanna Kim
Hanna Kim
RMReliza McGinnis
Reliza McGinnis
JLJiayu Liu
Jiayu Liu
CCClifford S. Cho
Clifford S. Cho
Solid tumors are known to be refractory to treatment due to a poorly perfused microenvironment that blocks immune cell infiltration and effective drug delivery. Histotripsy is a non-invasive focused ultrasound modality that generates cavitation microbubbles to mechanically disrupt solid tumors, resulting in decreased hypoxia and stimulation of tumor-targeted adaptive immune responses. In this study, we aim to investigate whether post-histotripsy hypoxia reduction and cytotoxic immune cell infiltration are associated with normalization of tumor vasculature and enhanced perfusion. Structural analysis of both treated and contralateral off-target tumors following partial histotripsy revealed significant vascular remodeling, enhanced vascular integrity, and decreased vascular leakage indicative of vascular normalization in multiple in vivo models of melanoma, hepatocellular carcinoma, and pancreatic adenocarcinoma. These effects appeared antigen-specific, as no remodeling was observed in contralateral off-target tumors of discordant pathology. Mechanistically, CXCR3+CD8+ T cells played a role in mediating these vascular changes, as genetic knockout of CD8 and pharmacological antagonism of CXCR3 impaired both remodeling and normalization. Additionally, significant changes in endothelial CXCR4 and Angiopoietin-1 and -2 expressions were observed following histotripsy, indicating their potential involvement in promoting vascular normalization and remodeling. Significant vascular remodeling was accompanied by enhanced tumor perfusion and intratumoral delivery of chemotherapeutic agents and therapeutic monoclonal antibodies. These findings suggest that histotripsy not only creates a more favorable microenvironment for immunotherapy, but also optimizes drug delivery into solid tumors. Combinatorial approaches using histotripsy with chemotherapy or immunotherapy may be a novel therapeutic strategy to overcome current limitations of conventional solid tumor therapies. Summary: Histotripsy reorganizes the tumor vasculature of solid cancers, promoting enhanced drug delivery into treated and non-targeted distant tumors.